Insiders Trades
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Latest filing published 09 Dec 2025 for Akero Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleTimothy Rolph
Insider track record
Disclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Timothy Rolph: trading record in brief
This profile gathers the share dealings of Timothy Rolph in Akero Therapeutics, Inc., where the filings describe the role as senior executive. Between 30 June 2021 and 9 December 2025, the trades on record add up to 44 filings.
Every open-market trade on record is a sale: 13 sales worth €1.2M. The rest of the record consists of 7 share grants and 19 option exercises. In 2025 alone, the filings show no purchases and 4 sales.
The record was last updated on 9 December 2025 with a transaction in Akero Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Timothy Rolph
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations44 total
238,339 sharesCommon StockSEC:0001193125-25-312116:0
43,810 sharesCommon StockSEC:0001193125-25-312116:1
3,527 shares@ US$28.352.0% of flowCommon StockSEC:0001193125-25-301155:0
37,100 shares0Common StockSEC:0001193125-25-288555:0
12,500 shares@ US$28.357.1% of flowCommon StockSEC:0001193125-25-236152:0
553 shares@ US$43.020.5% of flowCommon StockSEC:0000950170-25-114662:0
7,044 shares@ US$21.093.2% of flowCommon StockSEC:0001779479-25-000007:0
12,500 shares@ US$21.095.9% of flowCommon StockSEC:0000950170-25-104623:0
12,500 shares@ US$21.096.2% of flowCommon StockSEC:0000950170-25-094882:0
890 shares@ US$23.8680.5% of flowCommon StockSEC:0000950170-25-093318:0
1,129 shares@ US$54.841.6% of flowCommon StockSEC:0000950170-25-088638:0
2,358 shares@ US$53.9963.3% of flowCommon StockSEC:0000950170-25-085673:0
12,500 shares@ US$21.106.9% of flowCommon StockSEC:0000950170-25-083878:0
12,500 shares@ US$21.107.8% of flowCommon StockSEC:0000950170-25-067381:0
6,250 shares@ US$21.103.9% of flowCommon StockSEC:0000950170-25-059449:0
6,250 shares@ US$21.104.0% of flowCommon StockSEC:0000950170-25-052956:0
516 shares@ US$44.880.7% of flowCommon StockSEC:0000950170-25-039731:0
12,500 shares@ US$21.108.3% of flowCommon StockSEC:0000950170-25-035709:0
18,750 shares@ US$21.1012.8% of flowCommon StockSEC:0000950170-25-016493:0
14,986 shares@ US$19.879.5% of flowCommon StockSEC:0000950170-25-010707:0
14,000 shares0Common StockSEC:0000950170-25-004425:0
14,100 shares0Common StockSEC:0000950170-24-141259:0
3,800 shares@ US$19.872.4% of flowCommon StockSEC:0000950170-24-138134:0
2,368 shares@ US$30.792.3% of flowCommon StockSEC:0000950170-24-136025:0
537 shares@ US$26.180.4% of flowCommon StockSEC:0000950170-24-106458:0
25 of 44 declarations
